5.1.2 Notification 5.1.2.1 If the review of the Adverse Analytical Finding  does not reveal an applicable TUE or entitlement to the same as provided in the International Standard  for Therapeutic Use Exemptions , a departure from the International Standard  for Testing  and Investigations or the International Standard  for Laboratories that caused the Adverse Analytical Finding or that it is apparent that the Adverse Analytical Finding  was caused by an ingestion of the relevant Prohibited Substance through an authorized route, the Results Management  Authority shall promptly notify the Athlete  of: a) The Adverse Analytical Finding ; [Comment to Article 5.1.2.1 a): In the event that the Adverse Analytical Finding relates to salbutamol, formoterol, human chorionic gonadotrophin or another Prohibited Substance subject to specific Results Management requirements in a Technical Document, the Results Management Authority shall in addition comply with Article 5.1.2.2.